Russia says Medix, which received anti-COVID shots in two weeks is defying security concerns


Russia on Wednesday said the first batch of its Covid-19 vaccine would be ready in a couple of weeks, and some experts denied that the rapid approval of the drug in Moscow was a "non-expert" security issue.

Russia says Medix, which received anti-COVID shots in two weeks is defying security concerns


President Vladimir Putin said on Tuesday that after less than two months of human testing, Russia was the first country to regulate the COVID-19 vaccine.

The vaccine has not yet completed final tests. 10% have been successful in clinical trials and some scientists fear that Moscow will have a national prestige ahead of security.

"It seems that our foreign partners are realizing the specific competitive advantages of the Russian medicine drug and are trying to express opinions that our opinion is completely baseless," Health Minister Mikhail Murashko said on Wednesday.

He said the vaccine, developed by the Gamalaya Institute in Moscow would be made’ available to the public, including doctors, on a voluntary basis and would be ready soon.

"The first packages of medical a vaccine against coronavirus infection will arrive in the next two weeks, mainly to doctors," he said.

Alexander Gintzberg, director of the Gemelia Institute, said clinical trials would be published’ after its experts examined Russia.

He said the Russian plan could produce 5 million doses per month from December-January.

Kazakhstan plans to send government officials to Moscow later this month to discuss the distribution of the vaccine. (Reporting by Maria Kisliva and Andrei Kuzmin;

READ MORE 

Barcelona confirms positive coronavirus test ahead of Champions League quarter-finals



Post a Comment

0 Comments